| BCBS Oklahoma Medical Policies | Risankizumab-rzaa | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Number MED205.039 | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Subtalar Arthroereisis | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Surgical Treatment of Femoroacetabular Impingement | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Tildrakizumab-asmn | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Treatment for Duchenne Muscular Dystrophy | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Triamcinolone acetonide | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Ustekinumab and Associated Biosimilars | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Vedolizumab | 2025-08-15 |
| BCBS Oklahoma Medical Policies | Vertebral Axial Decompression | 2025-08-15 |